Richard Lussier, Ignacio Martinez, Duncan Whitney

Jan 22, 2008

Premium

Progenika Biopharma has named Richard Lussier to the posts of chief operating officer and general manager. Ignacio Martinez has been tapped as chief financial officer and Duncan Whitney is the new chief scientific officer.

Lussier spent 13 years at Applera in marketing and management with Applied Biosystems and Celera Genomics, and he recently worked with Solexa and Illumina.

Martinez started at Progenika in Spain as chief financial officer in 2005, and he previously was involved in high tech and biotech venture capital investing.

Whitney formerly was vice president of research and development at US Genomics and was vice president of technology development at Exact Sciences.

Filed under

Microarrays & Multiplexing

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.